{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:04:16Z","timestamp":1789391056608,"version":"build-2803163510"},"reference-count":311,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["26-15-00431"],"award-info":[{"award-number":["26-15-00431"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["26-15-00431"],"award-info":[{"award-number":["26-15-00431"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Extensive clinical studies have convincingly demonstrated that fungal infections constitute a mounting global health concern. Candida albicans, C. auris, Aspergillus fumigatus, and Cryptococcus neoformans were classified by the WHO as critical priority fungi due to their widespread prevalence, high mortality rates associated with invasive mycoses, and the increasing spread of resistant strains. The currently available antifungal arsenal, comprising four major classes (azoles, polyenes, echinocandins, and flucytosine), is critically insufficient. Resistance to these agents is escalating worldwide, while the approval of new drugs remains alarmingly slow. This review provides a comprehensive overview of the molecular mechanisms underlying resistance to conventional and emerging antimycotics in critical priority fungi, including recently approved and investigational agents such as oteseconazole, rezafungin, ibrexafungerp, fosmanogepix, and olorofim. It examines current strategies to overcome resistance, including combination therapy, drug repurposing, targeted delivery, antibiofilm approaches, immunotherapy, and the application of natural antifungal compounds. Special emphasis is placed on antifungal peptides (AFPs) derived from plants, animals, bacteria, and fungi, along with their synthetic analogs, all of which have demonstrated efficacy against critical priority fungi. The review primarily focuses on the molecular targets of AFPs and on the development of fungal resistance under prolonged exposure, compared with conventional antifungals, in order to evaluate their potential as prototypes for next-generation antimycotics.<\/jats:p>","DOI":"10.3390\/ijms27188141","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:09:51Z","timestamp":1789387791000},"page":"8141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["WHO Critical Priority Fungi: A Comprehensive Review of Antifungal Resistance, Emerging Therapeutic Strategies, and the Potential of Antifungal Peptides"],"prefix":"10.3390","volume":"27","author":[{"given":"Ekaterina I.","family":"Finkina","sequence":"first","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7696-2188","authenticated-orcid":false,"given":"Olga V.","family":"Shevchenko","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Gerasimova","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafima I.","family":"Fateeva","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2651-3739","authenticated-orcid":false,"given":"Sergey V.","family":"Balandin","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-249X","authenticated-orcid":false,"given":"Tatiana V.","family":"Ovchinnikova","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16\/10, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Almeida, F., Rodrigues, M.L., and Coelho, C. (2019). The Still Underestimated Problem of Fungal Diseases Worldwide. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00214"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Li, D., Fan, S., Zhao, H., Song, J., Guo, L., Li, W., Xu, X., and Li, Q. (2025). Worldwide Trends and Future Projections of Fungal Skin Disease Burden: A Comprehensive Analysis from the Global Burden of Diseases Study 2021. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1580221"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/myc.13264","article-title":"Superficial Mycoses, a Matter of Concern: Global and Indian Scenario\u2014An Updated Analysis","volume":"64","author":"Sharma","year":"2021","journal-title":"Mycoses"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global Incidence and Mortality of Severe Fungal Disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","first-page":"271","article-title":"Invasive Fungal Infection","volume":"116","author":"Wagener","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis","volume":"161","author":"Schlattmann","year":"2022","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.cmi.2022.06.031","article-title":"Main Human Inborn Errors of Immunity Leading to Fungal Infections","volume":"28","author":"Cifaldi","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-Associated Fungal Infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"ofad358","DOI":"10.1093\/ofid\/ofad358","article-title":"Mortality of Patients with Candidemia and COVID-19: A Systematic Review with Meta-Analysis","volume":"10","author":"Colaneri","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and Mortality of COVID-19-Associated Pulmonary Aspergillosis: A Systematic Review and Meta-Analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"key":"ref_12","unstructured":"World Health Organization (2025, September 10). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Costa-de-Oliveira, S., and Rodrigues, A.G. (2020). Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast\u2013Host\u2013Antifungal. Microorganisms, 8.","DOI":"10.3390\/microorganisms8020154"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"myae042","DOI":"10.1093\/mmy\/myae042","article-title":"Candida auris\u2014A systematic review to inform the World Health Organization fungal priority pathogens list","volume":"62","author":"Kim","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global Burden of Recurrent Vulvovaginal Candidiasis: A Systematic Review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: An initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"Chang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A Systematic Review of Fluconazole Resistance in Clinical Isolates of Cryptococcus Species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"ref_19","first-page":"e00140-18","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jiph.2022.08.004","article-title":"Development and research progress of anti-drug resistant fungal drugs","volume":"15","author":"Cui","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans Biofilms and Human Disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00451-18","DOI":"10.1128\/mBio.00451-18","article-title":"Conservation and Divergence in the Candida Species Biofilm Matrix Mannan\u2013Glucan Complex Structure, Function, and Genetic Control","volume":"9","author":"Dominguez","year":"2018","journal-title":"mBio"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2666-5247(24)00039-9","article-title":"Impact of Climate Change and Natural Disasters on Fungal Infections","volume":"5","author":"Seidel","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ii5","DOI":"10.1093\/jac\/dkw391","article-title":"The current treatment landscape: The need for antifungal stewardship programmes","volume":"71","author":"Bouza","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Berger, S., El Chazli, Y., Babu, A.F., and Coste, A.T. (2017). Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01024"},{"key":"ref_27","unstructured":"(2017). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 4th ed. (Standard No. CLSI M27)."},{"key":"ref_28","unstructured":"(2017). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 3rd ed. (Standard No. CLSI M38)."},{"key":"ref_29","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2026, July 31). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Yeasts; EUCAST Definitive Document E.Def 7.4. Available online: https:\/\/www.eucast.org\/fungi-afst\/methodology-and-instructions\/ast-of-yeasts\/."},{"key":"ref_30","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2026, July 31). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia-Forming Moulds; EUCAST Definitive Document E.Def 9.4. Available online: https:\/\/www.eucast.org\/fungi-afst\/methodology-and-instructions\/ast-of-moulds\/."},{"key":"ref_31","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2026, July 17). Breakpoint Tables for Interpretation of MICs for Antifungal Agents, Version 12.1. Available online: https:\/\/www.eucast.org\/fungi-afst\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-table\/."},{"key":"ref_32","unstructured":"World Health Organization (2026, July 31). Antifungal Agents in Clinical and Preclinical Development. Overview and Analysis. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/380498\/9789240105140-eng.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"i26","DOI":"10.1093\/jac\/dkx446","article-title":"Tolerability Profile of the Current Antifungal Armoury","volume":"73","author":"Mourad","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Carmo, A., Rocha, M., Pereirinha, P., Tom\u00e9, R., and Costa, E. (2023). Antifungals: From Pharmacokinetics to Clinical Practice. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050884"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal Therapeutic Drug Monitoring: Focus on Drugs without a Clear Recommendation","volume":"26","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"528521","DOI":"10.1155\/2012\/528521","article-title":"Fungal Biofilm Resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wiederhold, N.P. (2022). Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents. J. Fungi, 8.","DOI":"10.3390\/jof8080857"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/mmr.2025.13612","article-title":"Antifungal resistance: Emerging mechanisms and implications (Review)","volume":"32","author":"Kadariswantiningsih","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e0014223","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","volume":"37","author":"Puumala","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s42770-023-00999-z","article-title":"Recent drug development and treatments for fungal infections","volume":"54","author":"Roy","year":"2023","journal-title":"Braz. J. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3724\/abbs.2023011","article-title":"Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future?","volume":"55","author":"Deng","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1567-1364.2008.00470.x","article-title":"The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation","volume":"9","author":"Orsi","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"dlaf106","DOI":"10.1093\/jacamr\/dlaf106","article-title":"Understanding the mechanisms of resistance to azole antifungals in Candida species","volume":"7","author":"Li","year":"2025","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Whaley, S.G., Berkow, E.L., Rybak, J.M., Nishimoto, A.T., Barker, K.S., and Rogers, P.D. (2017). Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.02173"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e0106224","DOI":"10.1128\/aac.01062-24","article-title":"Deciphering the multidrug resistance paradigm in Candida auris","volume":"70","author":"Santana","year":"2026","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"De Francesco, M.A. (2023). Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe. Pathogens, 12.","DOI":"10.3390\/pathogens12111305"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3314\/jjmm.49.157","article-title":"Antifungal resistance mechanisms of Aspergillus","volume":"49","author":"Qiao","year":"2008","journal-title":"Jpn. J. Med. Mycol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.50.2.453-460.2006","article-title":"Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: Role in sterol biosynthesis and antifungal drug susceptibility","volume":"50","author":"Mellado","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Carolus, H., Pierson, S., Lagrou, K., and Van Dijck, P. (2020). Amphotericin B and Other Polyenes\u2014Discovery, Clinical Use, Mode of Action and Drug Resistance. J. Fungi, 6.","DOI":"10.3390\/jof6040321"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e01952-19","DOI":"10.1128\/mBio.01952-19","article-title":"A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans","volume":"10","author":"Cao","year":"2019","journal-title":"mBio"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00478-16","DOI":"10.1128\/mBio.00478-16","article-title":"Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans","volume":"7","author":"Huang","year":"2016","journal-title":"mBio"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2023-7-1","DOI":"10.7573\/dic.2023-7-1","article-title":"Antifungal resistance, combinations and pipeline: Oh my!","volume":"12","author":"Stover","year":"2023","journal-title":"Drugs Context"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yadav, A., Sah, S.K., Perlin, D.S., and Rustchenko, E. (2024). Candida albicans Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins. J. Fungi, 10.","DOI":"10.3390\/jof10030224"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11976","DOI":"10.1038\/s41598-020-68706-8","article-title":"FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure","volume":"10","author":"Silva","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_56","first-page":"20499361231161387","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13036-025-00539-3","article-title":"Simultaneous multigene integration in Aspergillus fumigatus using CRISPR\/Cas9 and endogenous counter-selectable markers","volume":"19","author":"Mach","year":"2025","journal-title":"J. Biol. Eng."},{"key":"ref_58","first-page":"61","article-title":"Recurrent Vulvovaginal Candidiasis: Focus on Candida albicans Resistance to Antifungal Drugs","volume":"26","author":"Kovyrshin","year":"2024","journal-title":"Probl. Med. Mycol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., and Tan, L. (2025). New antifungal strategies and drug development against WHO critical priority fungal pathogens. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1662442"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40588-024-00219-8","article-title":"Emerging Antifungal Resistance in Fungal Pathogens","volume":"11","author":"Hui","year":"2024","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gonzalez-Jimenez, I., Perlin, D.S., and Shor, E. (2023). Reactive oxidant species induced by antifungal drugs: Identity, origins, functions, and connection to stress-induced cell death. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1276406"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus","volume":"21","author":"Arendrup","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41564-023-01595-5","article-title":"Metabolic sensing tips the balance of drug tolerance in fungal meningitis","volume":"9","author":"Mottola","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e00156-21","DOI":"10.1128\/mBio.00156-21","article-title":"Unraveling Caspofungin Resistance in Cryptococcus neoformans","volume":"12","author":"Papon","year":"2021","journal-title":"mBio"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Mukaremera, L. (2023). The Cryptococcus wall: A different wall for a unique lifestyle. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011141"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e0013422","DOI":"10.1128\/msphere.00134-22","article-title":"Membrane Integrity Contributes to Resistance of Cryptococcus neoformans to the Cell Wall Inhibitor Caspofungin","volume":"7","author":"Ragsdale","year":"2022","journal-title":"mSphere"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/AAC.00854-09","article-title":"Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin","volume":"54","author":"Fortwendel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.2174\/1381612822666160530151209","article-title":"Repositioning the Old Fungicide Ciclopirox for New Medical Uses","volume":"22","author":"Tao","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1021\/acsomega.1c00273","article-title":"Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans","volume":"6","author":"Lin","year":"2021","journal-title":"ACS Omega"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2165\/11538110-000000000-00000","article-title":"Ciclopirox: Recent nonclinical and clinical data relevant to its use as a topical antimycotic agent","volume":"70","author":"Subissi","year":"2012","journal-title":"Drugs"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","unstructured":"U.S. Food and Drug Administration (2026, July 31). VIVJOA (Oteseconazole) Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215888s000lbl.pdf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e00341-19","DOI":"10.1128\/AAC.00341-19","article-title":"In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e02114-18","DOI":"10.1128\/AAC.02114-18","article-title":"Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161","volume":"63","author":"Monk","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e01304-19","DOI":"10.1128\/AAC.01304-19","article-title":"Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e02603-17","DOI":"10.1128\/AAC.02603-17","article-title":"Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data","volume":"62","author":"Lakota","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e01627-16","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults","volume":"61","author":"Sandison","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Garcia-Effron, G. (2020). Rezafungin\u2014Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins. J. Fungi, 6.","DOI":"10.3390\/jof6040262"},{"key":"ref_79","unstructured":"U.S. Food and Drug Administration (2026, July 31). REZZAYO (Rezafungin) Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2023\/217417Orig1s000Lbl.pdf."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1128\/AAC.00620-16","article-title":"Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species","volume":"60","author":"Locke","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"ofae702","DOI":"10.1093\/ofid\/ofae702","article-title":"Activity of Rezafungin against Echinocandin Non-Wild-Type Candida glabrata Clinical Isolates from a Global Surveillance Program","volume":"12","author":"Castanheira","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e02438-19","DOI":"10.1128\/AAC.02438-19","article-title":"Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method","volume":"64","author":"Helleberg","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e70362","DOI":"10.1111\/cts.70362","article-title":"Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science","volume":"18","author":"Walley","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"ref_84","unstructured":"U.S. Food and Drug Administration (2026, July 31). BREXAFEMME (Ibrexafungerp) Prescribing Information, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214900s002lbl.pdf."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e00161-17","DOI":"10.1128\/AAC.00161-17","article-title":"Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e01692-19","DOI":"10.1128\/AAC.01692-19","article-title":"In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor, against Candida glabrata Isolates with FKS Mutations","volume":"63","author":"Nunnally","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e01102-17","DOI":"10.1128\/AAC.01102-17","article-title":"Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species","volume":"61","author":"Schell","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e00833-17","DOI":"10.1128\/AAC.00833-17","article-title":"De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That Both Overlap and Are Distinct from Those Conferring Echinocandin Resistance","volume":"61","author":"Perez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e01510-19","DOI":"10.1128\/AAC.01510-19","article-title":"Activity of a Novel 1,3-Beta-D-Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata","volume":"63","author":"Ghannoum","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1154.e5","DOI":"10.1016\/j.cmi.2022.04.003","article-title":"\u0394F659 and F659S Substitutions at the HS1 of the FKS2 Gene, along with E655A and W715L Upstream and Downstream Substitutions, Correlate with High Ibrexafungerp MICs against Candida glabrata","volume":"28","author":"Mesquida","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e01324-23","DOI":"10.1128\/aac.01324-23","article-title":"In Vitro Activity of Ibrexafungerp against Clinically Relevant Echinocandin-Resistant Candida Strains","volume":"68","author":"Aldejohann","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Shaw, K.J., and Ibrahim, A.S. (2020). Fosmanogepix: A Review of the First-in-Class Broad-Spectrum Agent for the Treatment of Invasive Fungal Infections. J. Fungi, 6.","DOI":"10.3390\/jof6040239"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1038\/s41467-024-53512-x","article-title":"Structural Insights into the Inhibition Mechanism of Fungal GWT1 by Manogepix","volume":"15","author":"Dai","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_94","unstructured":"ClinicalTrials.gov (2026, July 31). A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants with Candidemia and\/or Invasive Candidiasis. Identifier: NCT05421858. U.S. National Library of Medicine, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05421858."},{"key":"ref_95","unstructured":"ClinicalTrials.gov (2026, July 31). A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients with Invasive Mold Infections. Identifier: NCT06925321. U.S. National Library of Medicine, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06925321."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jgar.2021.04.012","article-title":"Antimicrobial Activity of Manogepix, a First-in-Class Antifungal, and Comparator Agents Tested against Contemporary Invasive Fungal Isolates from an International Surveillance Programme (2018\u20132019)","volume":"26","author":"Pfaller","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e01387-19","DOI":"10.1128\/AAC.01387-19","article-title":"Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species","volume":"64","author":"Kapoor","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e00261-20","DOI":"10.1128\/AAC.00261-20","article-title":"Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility","volume":"64","author":"Liston","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e01508-24","DOI":"10.1128\/aac.01508-24","article-title":"TAC1b Mutation in Candida auris Decreases Manogepix Susceptibility Owing to Increased CDR1 Expression","volume":"69","author":"Hirayama","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e00680-25","DOI":"10.1128\/aac.00680-25","article-title":"Mutations in Transcription Factors That Confer Fluconazole Resistance Also Confer Reduced Susceptibility to Manogepix in Candida auris, Candida albicans, Candida parapsilosis, and Candida glabrata","volume":"69","author":"Barker","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 Represents a Novel Class of Antifungal Drug That Inhibits Dihydroorotate Dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e00231-18","DOI":"10.1128\/AAC.00231-18","article-title":"Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus","volume":"62","author":"Beckmann","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","unstructured":"Shionogi & Co., Ltd., and F2G Ltd. (2026, July 31). F2G and Shionogi Announce Positive Topline Results from Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome Followed by Standard of Care in Patients with Invasive Aspergillosis. 18 June 2026. Available online: https:\/\/www.shionogi.com\/global\/en\/news\/2026\/06\/e20260618_1.html."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/22221751.2022.2034485","article-title":"Resistance Profiling of Aspergillus fumigatus to Olorofim Indicates Absence of Intrinsic Resistance and Unveils the Molecular Mechanisms of Acquired Olorofim Resistance","volume":"11","author":"Buil","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_105","first-page":"29","article-title":"Aspergillus fumigatus Strains That Evolve Resistance to the Agrochemical Fungicide Ipflufenoquin In Vitro Are Also Resistant to Olorofim","volume":"9","author":"Storer","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1038\/s41467-024-54568-5","article-title":"Elevated Mutation Rates in Multi-Azole-Resistant Aspergillus fumigatus Drive Rapid Evolution of Antifungal Resistance","volume":"15","author":"Bottery","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e02280-16","DOI":"10.1128\/AAC.02280-16","article-title":"In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection","volume":"61","author":"Colley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e00690","DOI":"10.1002\/prp2.690","article-title":"Safety and Nonclinical and Clinical Pharmacokinetics of PC945, a Novel Inhaled Triazole Antifungal Agent","volume":"9","author":"Cass","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_109","unstructured":"ClinicalTrials.gov (2026, July 31). Safety and Efficacy of PC945 (Opelconazole) in Combination with Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study). Identifier: NCT05238116. U.S. National Library of Medicine, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05238116."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1038\/s41598-019-45890-w","article-title":"Antifungal Synergy of a Topical Triazole, PC945, with a Systemic Triazole against Respiratory Aspergillus fumigatus Infection","volume":"9","author":"Colley","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Toepfer, S., Keniya, M.V., Lackner, M., and Monk, B.C. (2024). Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris. J. Fungi, 10.","DOI":"10.3390\/jof10100698"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Murphy, S.E., and Bicanic, T. (2021). Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.759408"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Du, W., Wang, Q., and Zhao, M. (2025). Innovative antifungal strategies to combat drug-resistant Candida auris: Recent advances and clinical implications. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1641373"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Liu, D., Zhou, R., and Gao, X. (2025). Recent innovations and challenges in the treatment of fungal infections. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1676009"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11030-025-11247-x","article-title":"Drug repurposing: A promising drug discovery strategy for the treatment of emerging epidemic infectious disease","volume":"30","author":"Zhang","year":"2026","journal-title":"Mol. Divers."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkq046","article-title":"Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect","volume":"65","author":"Zhai","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e01921-19","DOI":"10.1128\/AAC.01921-19","article-title":"Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.","volume":"64","author":"Rossi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2147\/IDR.S466336","article-title":"Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses","volume":"17","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12247-026-10405-4","article-title":"Advanced Strategic Nanocarriers Containing Posaconazole as an Antifungal Drug for the Treatment of Fungal infection, Targeting topical, Ocular, Vaginal, and Systemic Delivery","volume":"21","author":"Shady","year":"2026","journal-title":"J. Pharm. Innov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal Amphotericin B (AmBisome(\u00ae)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40694-021-00126-3","article-title":"DC-SIGN targets amphotericin B-loaded liposomes to diverse pathogenic fungi","volume":"8","author":"Ambati","year":"2021","journal-title":"Fungal Biol. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"Abdelbary","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_123","unstructured":"Coste, A.T., and Vandeputte, P. (2015). Biofilms and Antifungal Resistance. Antifungals: From Genomics to Resistance and the Development of Novel Agents, Caister Academic Press."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"36441","DOI":"10.1021\/acsomega.5c04793","article-title":"Novel Pyrone-Based Biofilm Inhibitors against Azole-Resistant Candida albicans","volume":"10","author":"Yang","year":"2025","journal-title":"ACS Omega"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e00137-25","DOI":"10.1128\/aac.00137-25","article-title":"Antibiofilm activity of manogepix, ibrexafungerp, amphotericin B, rezafungin, and caspofungin against Candida spp. biofilms of reference and clinical strains","volume":"69","author":"Lebrat","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01397-07","article-title":"Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms","volume":"52","author":"Uppuluri","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis\u2014A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_128","unstructured":"ClinicalTrials.gov (2026, July 31). Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women with Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study, Available online: https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT06190509\/assessing-the-safety-immune-response-and-early-efficacy-of-a-candida-vaccine-in-women-with-recurrent-vulvovaginal-candidiasis-a-randomized-controlled-study."},{"key":"ref_129","unstructured":"ClinicalTrials.gov (2026, July 31). Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01067131?tab=study."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2022.05.057","article-title":"Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis","volume":"40","author":"Slarve","year":"2022","journal-title":"Vaccine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e03367-21.","DOI":"10.1128\/mbio.03367-21","article-title":"Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles","volume":"13","author":"Specht","year":"2022","journal-title":"mBio"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"114091","DOI":"10.1016\/j.isci.2025.114091","article-title":"Advances in fungal vaccine development: Progress in the face of emerging challenges","volume":"28","author":"Moses","year":"2025","journal-title":"iScience"},{"key":"ref_133","first-page":"10-1128","article-title":"The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Cryptococcus neoformans","volume":"9","author":"Espinosa","year":"2018","journal-title":"mBio"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e02145-19","DOI":"10.1128\/mBio.02145-19","article-title":"A Heat-Killed Cryptococcus Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e04955-22","DOI":"10.1128\/spectrum.04955-22","article-title":"Development of a Heat-Killed fbp1 Mutant Strain as a Therapeutic Agent To Treat Invasive Cryptococcus Infection","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e02328-22.","DOI":"10.1128\/mbio.02328-22","article-title":"Vaccination with Live or Heat-Killed Aspergillus fumigatus \u0394sglA Conidia Fully Protects Immunocompromised Mice from Invasive Aspergillosis","volume":"13","author":"Fernandes","year":"2022","journal-title":"mBio"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-025-01079-z","article-title":"Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model","volume":"10","author":"Li","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Loreto, \u00c9.S., Tondolo, J.S.M., Alves, S.H., and Santurio, J.M. (2017). Immunotherapy for Fungal Infections. Immunotherapy\u2014Myths, Reality, Ideas, Future, InTech.","DOI":"10.5772\/66164"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12281-026-00534-1","article-title":"Immunotherapeutic Approaches to Invasive Fungal Disease in the Immunocompromised Child","volume":"20","author":"Schmidt","year":"2026","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset","year":"2005","journal-title":"Ann. Hematol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of Transfusion with Granulocytes from G-CSF\/Dexamethasone\u2013Treated Donors in Neutropenic Patients with Infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Thakur, R., Anand, R., Tiwari, S., Singh, A.P., Tiwary, B.N., and Shankar, J. (2015). Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00429"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/IAI.02827-14","article-title":"Dendritic Cell-Based Immunization Ameliorates Pulmonary Infection with Highly Virulent Cryptococcus gattii","volume":"83","author":"Ueno","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.0803462","article-title":"Early NK Cell-Derived IFN-\u03b3 Is Essential to Host Defense in Neutropenic Invasive Aspergillosis","volume":"182","author":"Park","year":"2009","journal-title":"J. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Soe, W.M., Lim, J.H.J., Williams, D.L., Goh, J.G., Tan, Z., Sam, Q.H., Chotirmall, S.H., Ali, N.A.B.M., Lee, S.C., and Seet, J.E. (2020). Using Expanded Natural Killer Cells as Therapy for Invasive Aspergillosis. J. Fungi, 6.","DOI":"10.3390\/jof6040231"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Lauruschkat, C.D., Einsele, H., and Loeffler, J. (2018). Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives. J. Fungi, 4.","DOI":"10.3390\/jof4040137"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-Protective TH1 Immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/bmt.2008.271","article-title":"Clinical-Scale Generation of Human Anti-Aspergillus T Cells for Adoptive Immunotherapy","volume":"43","author":"Tramsen","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/s41409-019-0501-9","article-title":"Clinical-Scale Production of Aspergillus-Specific T Cells for the Treatment of Invasive Aspergillosis in the Immunocompromised Host","volume":"54","author":"Papadopoulou","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"eabh1209","DOI":"10.1126\/scitranslmed.abh1209","article-title":"CAR T Cells Targeting Aspergillus fumigatus Are Effective at Treating Invasive Pulmonary Aspergillosis in Preclinical Models","volume":"14","author":"Seif","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/j.ymthe.2025.09.003","article-title":"Adoptive Transfer of NK Cells Engineered with a CD5-Based Chimeric Antigen Receptor (SRCD5CAR) to Treat Invasive Fungal Infections","volume":"33","author":"Juan","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: Treatment with polyene and caspofungin combination and G-CSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cyto.2001.0889","article-title":"Recombinant Human Macrophage Colony-Stimulating Factor Augments Pulmonary Host Defences Against Aspergillus Fumigatus","volume":"15","author":"Gonzalez","year":"2001","journal-title":"Cytokine"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant Interferon-\u03b31b as Adjunctive Therapy for AIDS-Related Acute Cryptococcal Meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Delsing, C.E., Gresnigt, M.S., Leentjens, J., Preijers, F., Frager, F.A., Kox, M., Monneret, G., Venet, F., Bleeker-Rovers, C.P., and van de Veerdonk, F.L. (2014). Interferon-Gamma as Adjunctive Immunotherapy for Invasive Fungal Infections: A Case Series. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-166"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.201242711","article-title":"The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses","volume":"43","author":"Gresnigt","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.1402321","article-title":"IL-18 Triggered by the Nlrp3 Inflammasome Induces Host Innate Resistance in a Pulmonary Model of Fungal Infection","volume":"194","author":"Silva","year":"2015","journal-title":"J. Immunol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.2147\/IDR.S554647","article-title":"Natural Source-Derived Compounds with Antifungal Activity Against Medically Relevant Fungi","volume":"18","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es, A., and Ven\u00e2ncio, A. (2022). The Potential of Fatty Acids and Their Derivatives as Antifungal Agents: A Review. Toxins, 14.","DOI":"10.3390\/toxins14030188"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Ivanov, M., Kannan, A., Stojkovi\u0107, D.S., Glamo\u010dlija, J., Calhelha, R.C., Ferreira, I.C.F.R., Sanglard, D., and Sokovi\u0107, M. (2021). Camphor and Eucalyptol-Anticandidal Spectrum, Antivirulence Effect, Efflux Pumps Interference and Cytotoxicity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020483"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Ivanov, M., Kannan, A., Stojkovi\u0107, D.S., Glamo\u010dlija, J., Calhelha, R.C., Ferreira, I.C.F.R., Sanglard, D., and Sokovi\u0107, M. (2020). Flavones, Flavonols, and Glycosylated Derivatives-Impact on Candida albicans Growth and Virulence, Expression of CDR1 and ERG11, Cytotoxicity. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010027"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"152884","DOI":"10.1016\/j.phymed.2019.152884","article-title":"The antifungal activity and mechanisms of action of quantified extracts from berries, leaves and roots of Phytolacca tetramera","volume":"60","author":"Butassi","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Deshmukh, S.K., Gupta, M.K., Prakash, V., and Saxena, S. (2018). Endophytic Fungi: A Source of Potential Antifungal Compounds. J. Fungi, 4.","DOI":"10.3390\/jof4030077"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Finkina, E.I., Shevchenko, O.V., Fateeva, S.I., Tagaev, A.A., and Ovchinnikova, T.V. (2024). Antifungal Plant Defensins as an Alternative Tool to Combat Candidiasis. Plants, 13.","DOI":"10.3390\/plants13111499"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Shevchenko, O.V., Voropaev, A.D., Bogdanov, I.V., Ovchinnikova, T.V., and Finkina, E.I. (2024). Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans. Pathogens, 13.","DOI":"10.3390\/pathogens13121092"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Shevchenko, O.V., Bogdanov, I.V., Fateeva, S.I., Melnikova, D.N., Ignatova, A.A., Toropygin, I.Y., Ovchinnikova, T.V., and Finkina, E.I. (2025). Anticandidal Activity and Low Cytotoxicity of Modified Analogues of the Tobacco Defensin NaD1. Antibiotics, 14.","DOI":"10.3390\/antibiotics14111129"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1128\/AAC.00448-08","article-title":"In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis","volume":"52","author":"Tavares","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Vriens, K., Cools, T.L., Harvey, P.J., Craik, D.J., Spincemaille, P., Cassiman, D., Braem, A., Vleugels, J., Nibbering, P.H., and Drijfhout, J.W. (2015). Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132701"},{"key":"ref_173","first-page":"100407","article-title":"Plant-derived nodule-specific cysteine-rich peptides as potent antifungal agents against Cryptococcus neoformans: Mechanisms of action, chimeric peptide enhancement, and immunomodulatory effects","volume":"9","author":"Papp","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Finkina, E.I., Gerasimova, A.A., Shevchenko, O.V., Bogdanov, I.V., Tagaev, A.A., Voropaev, A.D., and Ovchinnikova, T.V. (2025). Modified Hevein-like Peptide from Amaranthus caudatus as a Promising Agent Against Pathogenic Candida Species. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17111406"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00284-024-03839-x","article-title":"Purification, Structural Characterization, and Anticandidal Activity of a Chitin-Binding Peptide with High Similarity to Hevein and Endochitinase Isolated from Pepper Seeds","volume":"81","author":"Taveira","year":"2024","journal-title":"Curr. Microbiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1134\/S1068162019020043","article-title":"Peptides of the Innate Immune System of Plants. Part I. Structure, Biological Activity and Mechanisms of Action","volume":"45","author":"Finkina","year":"2019","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/cbdd.13500","article-title":"Isolation, functional characterization, and biological properties of MCh-AMP1, a novel antifungal peptide from Matricaria chamomilla L.","volume":"93","author":"Seyedjavadi","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Loo, S., Kam, A., Xiao, T., and Tam, J.P. (2017). Bleogens: Cactus-Derived Anti-Candida Cysteine-Rich Peptides with Three Different Precursor Arrangements. Front. Plant Sci., 8.","DOI":"10.3389\/fpls.2017.02162"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/bip.22504","article-title":"Vicilin-like peptides from Capsicum baccatum L. seeds are \u03b1-amylase inhibitors and exhibit antifungal activity against important yeasts in medical mycology","volume":"102","author":"Nascimento","year":"2014","journal-title":"Biopolymers"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.peptides.2011.06.020","article-title":"Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation","volume":"32","author":"Mandal","year":"2011","journal-title":"Peptides"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acsinfecdis.2c00080","article-title":"Tachyplesin I Analogue Peptide as an Effective Antimicrobial Agent Against Candida Albicans\u2013Staphylococcus Aureus Poly-Biofilm Formation and Mixed Infection","volume":"8","author":"Miao","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Michira, B.B., Wang, Y., Mwangi, J., Wang, K., Asmamaw, D., Tadese, D.A., Gao, J., Khalid, M., Lu, Q.-M., and Lai, R. (2024). A Tachyplesin Antimicrobial Peptide from Theraphosidae Spiders with Potent Antifungal Activity Against Cryptococcus neoformans. Microorganisms, 12.","DOI":"10.3390\/microorganisms12122648"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1574-6968.2007.00850.x","article-title":"Gomesin, a Peptide Produced by the Spider Acanthoscurria Gomesiana, Is a Potent Anticryptococcal Agent That Acts in Synergism with Fluconazole","volume":"274","author":"Barbosa","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Rossi, D.C., Mu\u00f1oz, J.E., Carvalho, D.D., Belmonte, R., Faintuch, B., Borelli, P., Miranda, A., Taborda, C.P., and Daffre, S. (2012). Therapeutic Use of a Cationic Antimicrobial Peptide from the Spider Acanthoscurria Gomesiana in the Control of Experimental Candidiasis. BMC Microbiol., 12.","DOI":"10.1186\/1471-2180-12-28"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Bolosov, I.A., Finkina, E.I., Bogdanov, I.V., Safronova, V.N., Panteleev, P.V., and Ovchinnikova, T.V. (2024). Natural Gomesin-Like Peptides with More Selective Antifungal Activities. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121606"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02350646","article-title":"Antifungal Spectrum and Fungicidal Mechanism of an N-terminal Peptide of Bovine Lactoferrin","volume":"1","author":"Wakabayashi","year":"1996","journal-title":"J. Infect. Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Fernandes, K.E., and Carter, D.A. (2017). The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs Against Fungal Pathogens. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00002"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Chang, C.-K., Kao, M.-C., and Lan, C.-Y. (2021). Antimicrobial Activity of the Peptide LfcinB15 Against Candida albicans. J. Fungi, 7.","DOI":"10.3390\/jof7070519"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2583.2009.00907.x","article-title":"Drosomycin, an Essential Component of Antifungal Defence in Drosophila","volume":"18","author":"Zhang","year":"2009","journal-title":"Insect Mol. Biol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1038\/ncomms4154","article-title":"Nematode-Derived Drosomycin-Type Antifungal Peptides Provide Evidence for Plant-To-Ecdysozoan Horizontal Transfer of a Disease Resistance Gene","volume":"5","author":"Zhu","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1074\/jbc.274.14.9320","article-title":"Insect Immunity. Isolation from the Lepidopteran Heliothis Virescens of a Novel Insect Defensin with Potent Antifungal Activity","volume":"274","author":"Lamberty","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1021\/bi0103563","article-title":"Solution Structures of the Antifungal Heliomicin and a Selected Variant with Both Antibacterial and Antifungal Activities","volume":"40","author":"Lamberty","year":"2001","journal-title":"Biochemistry"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M311165200","article-title":"Defensins from Insects and Plants Interact with Fungal Glucosylceramides","volume":"279","author":"Thevissen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_194","first-page":"100486","article-title":"Antifungal Activity of ETD151 Against Azole-Susceptible and -Resistant Aspergillus fumigatus Clinical Isolates","volume":"9","author":"Rochard","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1074\/jbc.M002998200","article-title":"Insect Immunity. Constitutive Expression of a Cysteine-Rich Antifungal and a Linear Antibacterial Peptide in a Termite Insect","volume":"276","author":"Lamberty","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40409-016-0058-7","article-title":"Cloning and Purification of the First Termicin-Like Peptide from the Cockroach Eupolyphaga sinensis","volume":"22","author":"Liu","year":"2016","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"16905","DOI":"10.1038\/s41598-019-53402-z","article-title":"Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms","volume":"9","author":"Basso","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"31635","DOI":"10.1016\/S0021-9258(18)31742-3","article-title":"The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms","volume":"269","author":"Mor","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11274-023-03852-5","article-title":"Antifungal properties of cathelicidin LL-37: Current knowledge and future research directions","volume":"40","author":"Memariani","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Luo, X.-L., Li, J.-X., Huang, H.-R., Duan, J.-L., Dai, R.-X., Tao, R.-J., Yang, L., Hou, J., Jia, X.-M., and Xu, J.-F. (2019). LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00283"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.49.7.2845-2850.2005","article-title":"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37","volume":"49","author":"Ciornei","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.peptides.2015.07.023","article-title":"Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections","volume":"71","author":"Scarsini","year":"2015","journal-title":"Peptides"},{"key":"ref_203","first-page":"597","article-title":"Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection","volume":"10","author":"Peters","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"ftx072","DOI":"10.1093\/femspd\/ftx072","article-title":"Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans","volume":"75","author":"Liao","year":"2017","journal-title":"Pathog. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.00470-08","article-title":"Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3","volume":"53","author":"Krishnakumari","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"eaat0979","DOI":"10.1126\/sciadv.aat0979","article-title":"Human \u03b2-defensin 2 kills Candida albicans through phosphatidylinositol 4,5-bisphosphate-mediated membrane permeabilization","volume":"4","author":"Phan","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/BJ20111454","article-title":"LL37 and hBD-3 elevate the \u03b2-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic","volume":"441","author":"Chang","year":"2012","journal-title":"Biochem. J."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"001835","DOI":"10.1099\/jmm.0.001835","article-title":"Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris","volume":"73","author":"Shaban","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"107644","DOI":"10.1016\/j.micpath.2025.107644","article-title":"Anti-virulence and anti-efflux pump activity of synthetic defensins and histatin in Candida auris","volume":"205","author":"Shaban","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acs.biochem.6b01111","article-title":"Human \u03b1-Defensin 6 Self-Assembly Prevents Adhesion and Suppresses Virulence Traits of Candida albicans","volume":"56","author":"Chairatana","year":"2017","journal-title":"Biochemistry"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Morici, P., Fais, R., Rizzato, C., Tavanti, A., and Lupetti, A. (2016). Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167470"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/522427","article-title":"Human Lactoferrin-Derived Peptide\u2019s Antifungal Activities against Disseminated Candida albicans Infection","volume":"196","author":"Lupetti","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Brouwer, C., van der Linden, Y., Rios Carrasco, M., Alwasel, S., Abalkhail, T., Al-Otibi, F.O., Boekhout, T., and Welling, M.M. (2025). Synthetic Human Lactoferrin Peptide hLF(1-11) Shows Antifungal Activity and Synergism with Fluconazole and Anidulafungin Towards Candida albicans and Various Non-Albicans Candida Species, Including Candidozyma auris. Antibiotics, 14.","DOI":"10.3390\/antibiotics14070671"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e01240-22","DOI":"10.1128\/spectrum.01240-22","article-title":"Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species","volume":"10","author":"Fais","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10096-008-0553-z","article-title":"Human Antimicrobial Peptides\u2019 Antifungal Activity against Aspergillus fumigatus","volume":"27","author":"Lupetti","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.00652-09","article-title":"Antimicrobial Peptide hLF1-11 Directs Granulocyte-Macrophage Colony-Stimulating Factor-Driven Monocyte Differentiation toward Macrophages with Enhanced Recognition and Clearance of Pathogens","volume":"54","author":"Bogaards","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"van der Velden, W.J.F.M., van Iersel, T.M.P., Blijlevens, N.M.A., and Donnelly, J.P. (2009). Safety and Tolerability of the Antimicrobial Peptide Human Lactoferrin 1-11 (hLF1-11). BMC Med., 7.","DOI":"10.1186\/1741-7015-7-44"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/aem.61.3.1061-1067.1995","article-title":"Isolation and Characterization of Acidocin A and Cloning of the Bacteriocin Gene from Lactobacillus acidophilus","volume":"61","author":"Kanatani","year":"1995","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1271\/bbb.56.1212","article-title":"Purification and Some Properties of Acidocin 8912, a Novel Bacteriocin Produced by Lactobacillus acidophilus TK8912","volume":"56","author":"Tahara","year":"1992","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Antoshina, D.V., Balandin, S.V., Finkina, E.I., Bogdanov, I.V., Eremchuk, S.I., Kononova, D.V., Kovrizhnykh, A.A., and Ovchinnikova, T.V. (2024). Acidocin A and Acidocin 8912 Belong to a Distinct Subfamily of Class II Bacteriocins with a Broad Spectrum of Antimicrobial Activity. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810059"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1134\/S1068162026602405","article-title":"Bacterial Antimicrobial Peptide Acidocin A Inhibits Growth of Clinically Relevant Pathogens","volume":"52","author":"Balandin","year":"2026","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"22706","DOI":"10.3390\/ijms151222706","article-title":"The Cyclic Antibacterial Peptide Enterocin AS-48: Isolation, Mode of Action, and Possible Food Applications","volume":"15","author":"Pulido","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Cohen, D.G., Heidenreich, T.M., Schorey, J.W., Ross, J.N., Hammers, D.E., Vu, H.M., Moran, T.E., Winski, C.J., Stuckey, P.V., and Ross, R.L. (2024). Minimal Domain Peptides Derived from Enterocins Exhibit Potent Antifungal Activity. Front. Fungal Biol., 5.","DOI":"10.3389\/ffunb.2024.1506315"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1128\/JB.181.24.7421-7429.1999","article-title":"Characterization of a Novel, Antifungal, Chitin-Binding Protein from Streptomyces tendae T\u00fc901 That Interferes with Growth Polarity","volume":"181","author":"Bormann","year":"1999","journal-title":"J. Bacteriol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/jmbi.2001.4622","article-title":"Solution Structure, Backbone Dynamics and Chitin Binding of the Anti-Fungal Protein from Streptomyces tendae TU901","volume":"308","author":"Bormann","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e01777-18","DOI":"10.1128\/AAC.01777-18","article-title":"In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis","volume":"63","author":"Holzknecht","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00253-004-1600-z","article-title":"Small, Basic Antifungal Proteins Secreted from Filamentous Ascomycetes: A Comparative Study Regarding Expression, Structure, Function and Potential Application","volume":"65","author":"Marx","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/j.1742-4658.2009.07011.x","article-title":"Functional Aspects of the Solution Structure and Dynamics of PAF, a Highly Stable Antifungal Protein from Penicillium chrysogenum","volume":"276","author":"Batta","year":"2009","journal-title":"FEBS J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jobm.201100041","article-title":"The Small Molecular Mass Antifungal Protein of Penicillium chrysogenum\u2014A Mechanism of Action Oriented Review","volume":"51","author":"Leiter","year":"2011","journal-title":"J. Basic Microbiol."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Garrigues, S., Gand\u00eda, M., Castillo, L., Coca, M., Marx, F., Marcos, J.F., and Manzanares, P. (2018). Three Antifungal Proteins from Penicillium expansum: Different Patterns of Production and Antifungal Activity. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02370"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1007\/s00253-023-12749-0","article-title":"Novel Findings about the Mode of Action of the Antifungal Protein PeAfpA against Saccharomyces cerevisiae","volume":"107","author":"Marcos","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"e00826-21","DOI":"10.1128\/spectrum.00826-21","article-title":"A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans","volume":"10","author":"Zhang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Yang, Y., Wang, C., Gao, N., Lyu, Y., Zhang, L., Zhang, S., Wang, J., and Shan, A. (2020). A Novel Dual-Targeted \u03b1-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.548620"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Sch\u00f6pf, C., Geschwindt, A., Knapp, M., Seybold, A.C., Cora\u00e7a-Huber, D.C., Ausserlechner, M.J., Romanelli, A., and Marx, F. (2026). Amphibian-Derived Peptide Analog TB_KKG6K: A Powerful Drug Candidate against Candida albicans with Anti-Biofilm Efficacy. J. Fungi, 12.","DOI":"10.1101\/2025.08.22.671737"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jare.2024.09.017","article-title":"Optimizing therapeutic efficacy of antifungal peptides via strategic terminal amino acid modification","volume":"74","author":"Song","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Chou, S., Li, Q., Wu, H., Li, J., Chang, Y.-F., Shang, L., Li, J., Wang, Z., and Shan, A. (2021). Selective Antifungal Activity and Fungal Biofilm Inhibition of Tryptophan Center Symmetrical Short Peptide. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158231"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"e0234520","DOI":"10.1128\/AAC.02345-20","article-title":"Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity","volume":"65","author":"Duncan","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e02690-18","DOI":"10.1128\/AAC.02690-18","article-title":"Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment","volume":"63","author":"Woodburn","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"001663","DOI":"10.1099\/mic.0.001663","article-title":"Antifungal activity of the antimicrobial peptide RP557 against priority fungal pathogens","volume":"172","author":"Poester","year":"2026","journal-title":"Microbiology"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.2147\/IDR.S218778","article-title":"Functional Synergy of Antimicrobial Peptides and Chlorhexidine Acetate Against Gram-Negative\/Gram-Positive Bacteria and a Fungus In Vitro and In Vivo","volume":"12","author":"Zhu","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_241","unstructured":"Chen, Y., Chen, M., Huang, Y., Li, Y., Wang, Y., Qu, L., and Wang, W. (2016). Antibiotic Peptide and Preparation Method Therefor and Application Therefor. (US9273095B2), U.S. Patent."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1039\/D5NP00031A","article-title":"Natural Product-Derived Compounds in Clinical Trials and Drug Approvals","volume":"43","author":"Butler","year":"2026","journal-title":"Nat. Prod. Rep."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Ji, H.-X., Zou, Y.-L., Duan, J.-J., Jia, Z.-R., Li, X.-J., Wang, Z., Li, L., Li, Y.-W., Liu, G.-Y., and Tong, M.-Q. (2013). The Synthetic Melanocortin (CKPV)2 Exerts Anti-Fungal and Anti-Inflammatory Effects against Candida albicans Vaginitis via Inducing Macrophage M2 Polarization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056004"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jss.2005.08.009","article-title":"Inhibitory Effects of the Peptide (CKPV)2 on Endotoxin-Induced Host Reactions","volume":"131","author":"Gatti","year":"2006","journal-title":"J. Surg. Res."},{"key":"ref_245","unstructured":"Zengen Inc. (2026, August 21). Zengen Reports Positive Phase I\/II Trial Results of Its Peptide Molecule for Vaginal Yeast Infection. Available online: https:\/\/www.eurekalert.org\/news-releases\/796451."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"33464","DOI":"10.1074\/jbc.M001491200","article-title":"Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family","volume":"275","author":"Silva","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Sousa, C., Sahoo, A., Swain, S.S., Gupta, P., Silva, F., Azevedo, A.S., and Rodrigues, C.F. (2025). In Silico and In Vitro Potential Antifungal Insights of Insect-Derived Peptides in the Management of Candida sp. Infections. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157449"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1038\/s41598-018-29826-4","article-title":"Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation","volume":"8","author":"Ikonomopoulou","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Tanner, J.D., Deplazes, E., and Mancera, R.L. (2018). The Biological and Biophysical Properties of the Spider Peptide Gomesin. Molecules, 23.","DOI":"10.3390\/molecules23071733"},{"key":"ref_250","first-page":"205","article-title":"Structure-activity relationship studies of gomesin: Importance of the disulfide bridges for conformation, bioactivities, and serum stability","volume":"84","author":"Oliveira","year":"2006","journal-title":"Pept. Sci. Orig. Res. Biomol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/acsinfecdis.6b00045","article-title":"Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of \u03b2-Hairpin Peptides","volume":"2","author":"Edwards","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Buri, M.V., Domingues, T.M., Paredes-Gamero, E.J., Casaes-Rodrigues, R.L., Rodrigues, E.G., and Miranda, A. (2013). Resistance to Degradation and Cellular Distribution Are Important Features for the Antitumor Activity of Gomesin. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080924"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.00155-07","article-title":"Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity","volume":"52","author":"Simon","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.042411999","article-title":"Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants","volume":"99","author":"Tzou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e00111-18","DOI":"10.1128\/AAC.00111-18","article-title":"Fungicidal Potency and Mechanisms of \u03b8-Defensins against Multidrug-Resistant Candida Species","volume":"62","author":"Basso","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.286.5439.498","article-title":"A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated \u03b1-defensins","volume":"286","author":"Tang","year":"1999","journal-title":"Science"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1074\/jbc.M109117200","article-title":"Homodimeric \u03b8-Defensins from Rhesus macaque Leukocytes: Isolation, Synthesis, Antimicrobial Activities, and Bacterial Binding Properties of the Cyclic Peptides","volume":"277","author":"Tran","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/AAC.01090-07","article-title":"Microbicidal Properties and Cytocidal Selectivity of Rhesus Macaque Theta Defensins","volume":"52","author":"Tran","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/dkv301","article-title":"Rhesus \u03b8-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa","volume":"71","author":"Beringer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Antoshina, D.V., Balandin, S.V., Bogdanov, I.V., Vershinina, M.A., Sheremeteva, E.V., Toropygin, I.Y., Finkina, E.I., and Ovchinnikova, T.V. (2022). Antimicrobial Activity and Immunomodulatory Properties of Acidocin A, the Pediocin-like Bacteriocin with the Non-Canonical Structure. Membranes, 12.","DOI":"10.3390\/membranes12121253"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"183246","DOI":"10.1016\/j.bbamem.2020.183246","article-title":"Two small, cysteine-rich and cationic antifungal proteins from Penicillium chrysogenum: A comparative study of PAF and PAFB","volume":"1862","author":"Huber","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Sonderegger, C., V\u00e1radi, G., Galg\u00f3czy, L., Kocsub\u00e9, S., Posch, W., Borics, A., Dubrac, S., T\u00f3th, G.K., Wilflingseder, D., and Marx, F. (2018). The Evolutionary Conserved \u03b3-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01655"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00018-007-7364-8","article-title":"The Penicillium chrysogenum antifungal protein PAF, a promising tool for the development of new antifungal therapies and fungal cell biology studies","volume":"65","author":"Marx","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41598-018-20002-2","article-title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176","volume":"8","author":"Huber","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00210-004-1013-7","article-title":"The Penicillium chrysogenum-derived antifungal peptide shows no toxic effects on mammalian cells in the intended therapeutic concentration","volume":"371","author":"Szappanos","year":"2005","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2013.02.014","article-title":"In vivo application of a small molecular weight antifungal protein of Penicillium chrysogenum (PAF)","volume":"269","author":"Palicz","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00203-003-0578-8","article-title":"Characterization of the Penicillium chrysogenum antifungal protein PAF","volume":"180","author":"Kaiserer","year":"2003","journal-title":"Arch. Microbiol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/EC.00050-10","article-title":"The Antifungal Activity of the Penicillium chrysogenum Protein PAF Disrupts Calcium Homeostasis in Neurospora crassa","volume":"9","author":"Binder","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/emi.2016.116","article-title":"Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice","volume":"5","author":"Palicz","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"T\u00f3th, L., V\u00e1radi, G., Borics, A., Batta, G., Kele, Z., Vendrinszky, \u00c1., T\u00f3th, R., Ficze, H., T\u00f3th, G.K., and V\u00e1gv\u00f6lgyi, C. (2018). Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2). Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00393"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13568-016-0250-8","article-title":"NFAP2, a novel cysteine-rich anti-yeast protein from Neosartorya fischeri NRRL 181: Isolation and characterization","volume":"6","author":"Kele","year":"2016","journal-title":"AMB Express"},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, R., Nagy, F., T\u00f3th, Z., Forg\u00e1cs, L., T\u00f3th, L., V\u00e1radi, G., T\u00f3th, G.K., Vad\u00e1szi, K., Borman, A.M., and Majoros, L. (2021). The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020771"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00253-026-13782-5","article-title":"Engineering Penicillium expansum Antifungal Proteins Unveils New Clues about Their Mode of Action","volume":"110","author":"Thomson","year":"2026","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/AAC.00365-13","article-title":"Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans","volume":"57","author":"Hayes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1021\/acs.jmedchem.1c00551","article-title":"Discovery of Hyperstable Noncanonical Plant-Derived Epidermal Growth Factor Receptor Agonist and Analogs","volume":"64","author":"Loo","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Rather, I.A., Sabir, J.S.M., Asseri, A.H., and Ali, S. (2022). Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris. J. Fungi., 8.","DOI":"10.3390\/jof8020204"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s11274-010-0643-9","article-title":"Antimicrobial peptides derived from different animals: Comparative studies of antimicrobial properties, cytotoxicity and mechanism of action","volume":"27","author":"Han","year":"2011","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Finkina, E.I., Bogdanov, I.V., Ignatova, A.A., Kanushkina, M.D., Egorova, E.A., Voropaev, A.D., Stukacheva, E.A., and Ovchinnikova, T.V. (2022). Antifungal Activity, Structural Stability, and Immunomodulatory Effects on Human Immune Cells of Defensin from the Lentil Lens culinaris. Membranes, 12.","DOI":"10.3390\/membranes12090855"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10123-022-00290-5","article-title":"Fungicidal activity of human antimicrobial peptides and their synergistic interaction with common antifungals against multidrug-resistant Candida auris","volume":"26","author":"Shaban","year":"2023","journal-title":"Int. Microbiol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/cbic.200700560","article-title":"Linear analogues of human beta-defensin 3: Concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells","volume":"9","author":"Liu","year":"2008","journal-title":"ChemBioChem"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","article-title":"Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins","volume":"171","author":"Taggart","year":"2003","journal-title":"J. Immunol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1128\/AAC.00699-16","article-title":"The Antimicrobial Peptides P-113Du and P-113Tri Function against Candida albicans","volume":"60","author":"Lin","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-051X.1997.tb01834.x","article-title":"Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins","volume":"24","author":"Paquette","year":"1997","journal-title":"J. Clin. Periodontol."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Woodburn, K.W., Jaynes, J.M., and Clemens, L.E. (2019). Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01688"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"e00290-22","DOI":"10.1128\/msphere.00290-22","article-title":"The Membrane Activity of the Amphibian Temporin B Peptide Analog TB_KKG6K Sheds Light on the Mechanism That Kills Candida albicans","volume":"7","author":"Kakar","year":"2022","journal-title":"mSphere"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"43820","DOI":"10.1021\/acsami.9b12706","article-title":"Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging","volume":"11","author":"Song","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Li, S., Wang, Y., Zhou, J., Wang, J., Zhang, M., and Chen, H. (2023). Structural Characterization, Cytotoxicity, and the Antifungal Mechanism of a Novel Peptide Extracted from Garlic (Allium sativa L.). Molecules, 28.","DOI":"10.3390\/molecules28073098"},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"McColl, A.I., Bleackley, M.R., Anderson, M.A., and Lowe, R.G.T. (2018). Resistance to the Plant Defensin NaD1 Features Modifications to the Cell Wall and Osmo-Regulation Pathways of Yeast. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01648"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"e01273-24","DOI":"10.1128\/spectrum.01273-24","article-title":"The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro","volume":"13","author":"Bende","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"146558","DOI":"10.1016\/j.ijbiomac.2025.146558","article-title":"Beyond plasma membrane disruption: Novel antifungal mechanism of Neosartorya (Aspergillus) fischeri antifungal protein 2 in Candida albicans","volume":"327","author":"Zsindely","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-1097(03)00121-6","article-title":"Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans","volume":"220","author":"Fitzgerald","year":"2003","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.00094-07","article-title":"Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype","volume":"51","author":"Coleman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Tati, S., Jang, W.S., Li, R., Kumar, R., Puri, S., and Edgerton, M. (2013). Histatin 5 Resistance of Candida glabrata Can Be Reversed by Insertion of Candida albicans Polyamine Transporter-Encoding Genes DUR3 and DUR31. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061480"},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Hampe, I.A.I., Friedman, J., Edgerton, M., and Morschh\u00e4user, J. (2017). An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006655"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/AAC.02087-13","article-title":"Agp2p, the Plasma Membrane Transregulator of Polyamine Uptake, Regulates the Antifungal Activities of the Plant Defensin NaD1 and Other Cationic Peptides","volume":"58","author":"Bleackley","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"e01097-19","DOI":"10.1128\/AAC.01097-19","article-title":"Screening the Saccharomyces cerevisiae Nonessential Gene Deletion Library Reveals Diverse Mechanisms of Action for Antifungal Plant Defensins","volume":"63","author":"Parisi","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.1073\/pnas.160077797","article-title":"A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii)","volume":"97","author":"Thevissen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.febslet.2005.02.043","article-title":"SKN1, a Novel Plant Defensin-Sensitivity Gene in Saccharomyces cerevisiae, Is Implicated in Sphingolipid Biosynthesis","volume":"579","author":"Thevissen","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1099\/mic.0.026120-0","article-title":"Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface","volume":"155","author":"Harris","year":"2009","journal-title":"Microbiology"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/AAC.50.1.324-331.2006","article-title":"Distinct Antifungal Mechanisms: \u03b2-Defensins Require Candida albicans Ssa1 Protein, while Trk1p Mediates Activity of Cysteine-Free Cationic Peptides","volume":"50","author":"Vylkova","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/AAC.44.2.348-354.2000","article-title":"Candida albicans Mutants Deficient in Respiration Are Resistant to the Small Cationic Salivary Antimicrobial Peptide Histatin 5","volume":"44","author":"Gyurko","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Aerts, A.M., Bammens, L., Govaert, G., Carmona-Gutierrez, D., Madeo, F., Cammue, B.P.A., and Thevissen, K. (2011). The Antifungal Plant Defensin HsAFP1 from Heuchera sanguinea Induces Apoptosis in Candida albicans. Front. Microbiol., 2.","DOI":"10.3389\/fmicb.2011.00047"},{"key":"ref_303","first-page":"579","article-title":"Antimicrobial peptide MUC7 12-mer activates the calcium\/calcineurin pathway in Candida albicans","volume":"10","author":"Lis","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2958.2009.06936.x","article-title":"The antifungal protein PAF interferes with PKC\/MPK and cAMP\/PKA signalling of Aspergillus nidulans","volume":"75","author":"Binder","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/EC.00285-12","article-title":"Bcr1 Functions Downstream of Ssd1 to Mediate Antimicrobial Peptide Resistance in Candida albicans","volume":"12","author":"Jung","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/EC.00402-07","article-title":"SSD1 Is Integral to Host Defense Peptide Resistance in Candida albicans","volume":"7","author":"Gank","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/AAC.01439-12","article-title":"Chemical Genomic Screening of a Saccharomyces cerevisiae Genomewide Mutant Collection Reveals Genes Required for Defense against Four Antimicrobial Peptides Derived from Proteins Found in Human Saliva","volume":"57","author":"Lis","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Jiang, L., Yang, S., Li, Y., Zhang, Y., Ren, X., Liu, W., Fu, H., Bao, C., Qi, Q., and Liu, T. (2026). Integrative computational-experimental discovery and translation of antifungal peptides for multidrug-resistant fungi. Front. Microbiol., 17.","DOI":"10.3389\/fmicb.2026.1861239"},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Wu-Mo, C., Flores-Gonz\u00e1lez, A., Mel\u00e9ndez-Delgado, J., Ortiz-G\u00f3mez, V., Mel\u00e9ndez-Gonz\u00e1lez, H., and Maldonado-Hern\u00e1ndez, R. (2026). Artificial Intelligence-Driven Discovery and Optimization of Antimicrobial Peptides Targeting ESKAPE Pathogens and Multidrug-Resistant Fungi. Microorganisms, 14.","DOI":"10.3390\/microorganisms14030591"},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Saleem, N., Kumar, N., El-Omar, E., Willcox, M., and Jiang, X.T. (2025). Harnessing Machine Learning Approaches for the Identification, Characterization, and Optimization of Novel Antimicrobial Peptides. Antibiotics, 14.","DOI":"10.3390\/antibiotics14121263"},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Tang, Z., Ma, Q., Chen, X., Chen, T., Ying, Y., Xi, X., Wang, L., Ma, C., Shaw, C., and Zhou, M. (2021). Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs). Antibiotics, 10.","DOI":"10.3390\/antibiotics10080990"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:22:50Z","timestamp":1789388570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":311,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188141"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188141","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}